| Hepatitis C, porphyria cutanea tarda and liver iron: an update F Ryan Caballes, H Sendi, HL Bonkovsky Liver International 32 (6), 880-893, 2012 | 138 | 2012 |
| The role of liver microenvironment in hepatic metastasis T Williamson, N Sultanpuram, H Sendi Clinical and translational medicine 8, 1-7, 2019 | 57 | 2019 |
| miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling H Sendi, I Mead, M Wan, M Mehrab-Mohseni, K Koch, A Atala, ... PloS one 13 (7), e0200847, 2018 | 54 | 2018 |
| T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D H Sendi, M Mehrab-Mohseni, MR Zali, H Norder, LO Magnius Journal of general virology 86 (9), 2451-2458, 2005 | 46 | 2005 |
| CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA H Sendi, M Mehrab-Mohseni, S Shahraz, H Norder, SM Alavian, ... Journal of clinical virology 46 (3), 259-264, 2009 | 33 | 2009 |
| Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis H Sendi, M Yazdimamaghani, M Hu, N Sultanpuram, J Wang, AS Moody, ... Cancer research 82 (1), 105-113, 2022 | 32 | 2022 |
| Dual role of miR-122 in molecular pathogenesis of viral hepatitis H Sendi Hepatitis monthly 12 (5), 312, 2012 | 30 | 2012 |
| miR‐122 decreases HCV entry into hepatocytes through binding to the 3′ UTR of OCLN mRNA H Sendi, M Mehrab‐Mohseni, DM Foureau, S Ghosh, TL Walling, ... Liver International 35 (4), 1315-1323, 2015 | 28 | 2015 |
| Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome T Ghaziani, H Sendi, S Shahraz, P Zamor, HL Bonkovsky World journal of gastroenterology: WJG 20 (39), 14142, 2014 | 25 | 2014 |
| Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection T Ghaziani, SM Alavian, MR Zali, S Shahraz, M Agah, KP Jensen, ... Hepatology Research 37 (3), 172-178, 2007 | 22 | 2007 |
| Nanoparticle drug delivery can reduce the hepatotoxicity of therapeutic cargo F Yang, Y Medik, L Li, X Tian, D Fu, KLR Brouwer, K Wagner, B Sun, ... Small 16 (7), 1906360, 2020 | 21 | 2020 |
| T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: a study from the South-Eastern region of Iran S Assar, M Kazemi Arababadi, M Mohit, B Nasiri Ahmadabadi, ... Clinical Laboratory 58 (1), 53, 2012 | 21 | 2012 |
| CCR5 Δ 32 mutation is not prevalent in Iranians with chronic HBV infection H Khorramdelazad, E Hakimizadeh, G Hassanshahi, M Rezayati, H Sendi, ... Journal of medical virology 85 (6), 964-968, 2013 | 20 | 2013 |
| Hemochromatosis mutations in Iranians with hepatitis B virus infection H Sendi, T Ghaziani, MR Zali, P Adibi, M Agah, M Jazayeri, S Shahraz, ... Clinical Infectious Diseases 40 (3), e19-e21, 2005 | 11 | 2005 |
| Baseline hepatic levels of miR-29b and claudin are respectively associated with the stage of fibrosis and HCV RNA in hepatitis C H Sendi, M Mehrab-Mohseni, MW Russo, N Steuerwald, C Jacobs, ... Clinical & experimental gastroenterology & hepatology 1 (1), 2019 | 4 | 2019 |
| HFE gene mutations in cryptogenic cirrhosis patients H Sendi, M Mehrab-Mohseni Hepatitis Monthly 12 (1), 48-49, 2012 | 4 | 2012 |
| Iron and hepatitis C TK Narang, H Sendi, MW Scobey, HL Bonkovsky Current Hepatitis Reports 9, 169-177, 2010 | 4 | 2010 |
| Glutathione-S-transferase M1, T1 and P1 gene polymorphisms in type I autoimmune hepatitis: a case-control study. L Alidoust, M Zafarghandi, M Agah, H Sendi, SM Alavian, MR Zali | 4 | 2007 |
| HEME OXYGENASE 1 [HMOX1] EXPRESSION IS UPREGULATED BY HCV IN HUMAN HEPATOMA CELLS AND IS NORMALIZED THROUGH IFN TREATMENT: 1372 H Sendi, M Mehrab-Mohseni, N Steuerwald, HL Bonkovsky Hepatology 50, 936A, 2009 | 1 | 2009 |
| LEGALON-SIL DOWN-REGULATES HCV CORE AND NS5A EXPRESSION IN HUMAN HEPATOMA LINES EXPRESSING FULL-LENGTH HCV: 814 M Mehrab-Mohseni, N Steuerwald, H Sendi, J Parsons, HL Bonkovsky Hepatology 50, 685A-686A, 2009 | 1 | 2009 |
Saeid Shahraz MD, PHDAssistant Professor of Medicine, Tufts Medical Center, ICRHPSVerified email at tuftsmedicalcenter.org
